[HTML][HTML] Branched-chain α-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes

KA Strauss, VJ Carson, K Soltys, ME Young… - Molecular genetics and …, 2020 - Elsevier
Over the past three decades, we studied 184 individuals with 174 different molecular variants
of branched-chain α-ketoacid dehydrogenase activity, and here delineate essential clinical …

[HTML][HTML] Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2

KA Strauss, EG Puffenberger… - … England Journal of …, 2006 - Mass Medical Soc
<p id="p001">Contactin-associated protein-like 2 (CASPR2) is encoded by <italic>CNTNAP2</italic>
and clusters voltage-gated potassium channels (K<sub>v</sub>1.1) at the nodes …

Type I glutaric aciduria, part 1: natural history of 77 patients

KA Strauss, EG Puffenberger… - American Journal of …, 2003 - Wiley Online Library
Kevin A. Strauss is a practicing pediatrician at the Clinic for Special Children in Strasburg,
Pennsylvania. He is interested in brain development and function, with a particular focus on …

Diagnosis and treatment of maple syrup disease: a study of 36 patients

DH Morton, KA Strauss, DL Robinson… - …, 2002 - publications.aap.org
Objective. To evaluate an approach to the diagnosis and treatment of maple syrup disease (MSD).
Methods. Family histories and molecular testing for the Y393N mutation of the E1α …

[HTML][HTML] Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial

KA Strauss, MA Farrar, F Muntoni, K Saito… - Nature medicine, 2022 - nature.com
SPR1NT ( NCT03505099 ) was a Phase III, multicenter, single-arm study to investigate the
efficacy and safety of onasemnogene abeparvovec for presymptomatic children with biallelic …

[HTML][HTML] Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial

KA Strauss, MA Farrar, F Muntoni, K Saito… - Nature medicine, 2022 - nature.com
Most children with biallelic SMN1 deletions and three SMN2 copies develop spinal muscular
atrophy (SMA) type 2. SPR1NT ( NCT03505099 ), a Phase III, multicenter, single-arm trial, …

Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia

…, L Bataller, I Illa, S Markx, KA Strauss… - Annals of …, 2011 - Wiley Online Library
Objective To report clinical and immunological investigations of contactin‐associated protein‐like
2 (Caspr2), an autoantigen of encephalitis and peripheral nerve hyperexcitability (PNH…

[HTML][HTML] Genetic mapping and exome sequencing identify variants associated with five novel diseases

…, NL Rider, S Gabriel, DH Morton, KA Strauss - PloS one, 2012 - journals.plos.org
The Clinic for Special Children (CSC) has integrated biochemical and molecular methods
into a rural pediatric practice serving Old Order Amish and Mennonite (Plain) children. Among …

Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT

…, AK Batta, AS Knisely, DL Robinson, KA Strauss… - Nature …, 2003 - nature.com
Familial hypercholanemia (FHC) is characterized by elevated serum bile acid concentrations,
itching, and fat malabsorption 1 , 2 . We show here that FHC in Amish individuals is …

[PDF][PDF] Mutations in DDX3X are a common cause of unexplained intellectual disability with gender-specific effects on Wnt signaling

…, A Myers, MC Kruer, Q Stein, KA Strauss… - The American Journal of …, 2015 - cell.com
Intellectual disability (ID) affects approximately 1%–3% of humans with a gender bias
toward males. Previous studies have identified mutations in more than 100 genes on the X …